Inhaltsverzeichnis
Auswahl der wissenschaftlichen Literatur zum Thema „Boron-neutron capture therapy“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Boron-neutron capture therapy" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Boron-neutron capture therapy"
Taskaev, S. Yu. „Boron Neutron Capture Therapy“. Physics of Atomic Nuclei 84, Nr. 2 (März 2021): 207–11. http://dx.doi.org/10.1134/s106377882101021x.
Der volle Inhalt der QuelleONO, Koji, Minoru SUZUKI, Shinichiro MASUNAGA, Natsuko KONDO, Yoshinori SAKURAI, Hiroki TANAKA, Yuko KINASHI und Akira MARUHASHI. „Boron Neutron Capture Therapy“. RADIOISOTOPES 61, Nr. 4 (2012): 209–22. http://dx.doi.org/10.3769/radioisotopes.61.209.
Der volle Inhalt der QuelleFREEMANTLE, MICHAEL. „BORON NEUTRON CAPTURE THERAPY“. Chemical & Engineering News 80, Nr. 34 (26.08.2002): 13. http://dx.doi.org/10.1021/cen-v080n034.p013.
Der volle Inhalt der QuelleBeddoe, A. H. „Boron neutron capture therapy.“ British Journal of Radiology 70, Nr. 835 (Juli 1997): 665–67. http://dx.doi.org/10.1259/bjr.70.835.9245876.
Der volle Inhalt der QuelleSlatkin, Daniel N. „Boron neutron-capture therapy“. Neutron News 1, Nr. 4 (Januar 1990): 25–28. http://dx.doi.org/10.1080/10448639008229357.
Der volle Inhalt der QuelleOta, Ichiro, und Tadashi Kitahara. „Boron Neutron Capture Therapy (BNCT)“. Practica Oto-Rhino-Laryngologica 107, Nr. 12 (2014): 937–46. http://dx.doi.org/10.5631/jibirin.107.937.
Der volle Inhalt der Quelle&NA;. „Improving boron neutron capture therapy“. Inpharma Weekly &NA;, Nr. 971 (Januar 1995): 8. http://dx.doi.org/10.2165/00128413-199509710-00016.
Der volle Inhalt der QuelleMumot, M. „325. Boron Neutron Capture Therapy“. Reports of Practical Oncology & Radiotherapy 8 (2003): S354—S355. http://dx.doi.org/10.1016/s1507-1367(03)70808-6.
Der volle Inhalt der QuelleKato, I. „S17.1 Boron neutron capture therapy“. Oral Oncology Supplement 1, Nr. 1 (Januar 2005): 63. http://dx.doi.org/10.1016/s1744-7895(05)80118-x.
Der volle Inhalt der QuelleMonti, V., M. Costa, E. Durisi, E. Mafucci, A. Calamida, A. I. Castro Campoy, A. Fontanilla, L. Russo und R. Bedogni. „Neutron spectroscopy for Boron Neutron Capture Therapy beams characterization“. Journal of Instrumentation 19, Nr. 05 (01.05.2024): C05036. http://dx.doi.org/10.1088/1748-0221/19/05/c05036.
Der volle Inhalt der QuelleDissertationen zum Thema "Boron-neutron capture therapy"
Howard, William Bruce. „Accelerator-based boron neutron capture therapy“. Thesis, Massachusetts Institute of Technology, 1997. http://hdl.handle.net/1721.1/44479.
Der volle Inhalt der QuelleHefne, Jameel. „Neutron spectrum measurement for Boron Neutron Capture Therapy“. Diss., Georgia Institute of Technology, 1996. http://hdl.handle.net/1853/16625.
Der volle Inhalt der QuelleGoorley, John Timothy 1974. „Boron neutron capture therapy treatment planning improvements“. Thesis, Massachusetts Institute of Technology, 1998. http://hdl.handle.net/1721.1/49670.
Der volle Inhalt der QuelleIncludes bibliographical references.
The Boron Neutron Capture Therapy (BNCT) treatment planning process of the Harvard/MIT team used for their clinical Phase I trials is very time consuming. If BNCT proves to be a successful treatment, this process must be made more efficient. Since the Monte Carlo treatment planning calculations were the most time consuming aspect of the treatment planning process, requiring more than thirty six hours for scoping calculations of three to five beams and final calculations for two beams, it was targeted for improvement. Three approaches were used to reduce the calculation times. A statistical uncertainty analysis was performed on doses rates and showed that a fewer number of particles could not be used and still meet uncertainty requirements in the region of interest. Unused features were removed and assumptions specific to the Harvard/MIT BNCT treatment planning calculations were hard wired into MCNP by Los Alamos personnel, resulting in a thirty percent decrease in runtimes. MCNP was also installed in parallel on the treatment planning computers, allowing a factor of improvement by roughly the number of computers linked together in parallel. After theses enhancements were made, the final executable, MCNPBNCT, was tested by comparing its calculated dose rates against the previously used executable, MCNPNEHD. Since the dose rates in close agreement, MCNPBNCT was adopted. The final runtime improvement to a single beam scoping run by linking the two 200MHz Pentium Pro computers was to reduce the wall clock runtime from 2 hours thirty minutes to fifty nine minutes. It is anticipated that the addition of ten 900 MHz CPUs will further reduce this calculation to three minutes, giving the medical physicist or radiation oncologist the freedom to use an iterative approach to try different radiation beam orientations to optimize treatment. Additional aspects of the treatment planning process were improved. The previously unrecognized phenomenon of peak dose movement during irradiation and its potential for overdosing the subject was identified. A method of predicting its occurrence was developed to prevent this from occurring. The calculated dose rate was also used to create dose volume histograms and volume averaged doses. These data suggest an alternative method for categorizing the subjects, rather than by peak tissue dose.
by John Timothy Goorley.
S.M.
Matalka, Khalid Zuhair. „Boron neutron capture therapy of brain tumors /“. The Ohio State University, 1992. http://rave.ohiolink.edu/etdc/view?acc_num=osu148778039326795.
Der volle Inhalt der QuelleGuidi, Claretta. „Sviluppo e applicazioni della boron neutron capture therapy“. Bachelor's thesis, Alma Mater Studiorum - Università di Bologna, 2017. http://amslaurea.unibo.it/13399/.
Der volle Inhalt der QuelleShah, Jungal (Jugal Kaushik). „Hypoxia-selective compounds for boron neutron capture therapy“. Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/44829.
Der volle Inhalt der Quelle"June 2008."
Includes bibliographical references.
Boron neutron capture therapy (BNCT) is a biochemically targeted form of radiotherapy for cancer. In BNCT, a compound labeled with the stable isotope boron-10 is systemically administered, and tumor cells selectively uptake the boron-10 containing compound at higher concentrations than normal cells. A general problem with the tumor seeking compounds is that drug delivery is dependent upon sufficient vascularization within the tumor. To investigate the possibility of delivering boron to hypoxic regions of tumor, a new boronated nitroimidazole delivery agent has been synthesized as a carrier of boron-10 for BNCT. It is expected that this will be used in combination with the existing boron carrier boronophenylalanine-fructose to treat solid tumors. An immunohistochemical protocol to visualize hypoxia was tested and refined to confirm the suitability of two tumor models established in the lab for hypoxia related uptake studies. The immunohistochemical protocol is used to detect pimonidazole, which localizes at hypoxic regions in tissue and is the parent compound for the new hypoxia-selective boron carrier. The protocol was used to test and confirm the suitability of a hypoxic in vivo tumor model. Two tumor lines were tested: SCCVII squamous cell carcinoma and EMT-6 murine mammary carcinoma. Both exhibited hypoxia. Finally, quantitative studies using Inductive Coupled Plasma Atomic Emission Spectrum demonstrated that the synthesized boronated nitroimidazole reaches suitable concentrations in SCCVII and F98 tumor. Future therapeutic studies are required to empirically confirm the effectiveness of this compound.
by Jugal Shah.
S.B.
Wang, Zhonglu. „Design of a Boron Neutron Capture Enhanced Fast Neutron Therapy Assembly“. Diss., Georgia Institute of Technology, 2006. http://hdl.handle.net/1853/14100.
Der volle Inhalt der QuelleSweezy, Jeremy Ed. „Development of a boron neutron capture enhanced fast neutron therapy beam“. Diss., Georgia Institute of Technology, 2002. http://hdl.handle.net/1853/17107.
Der volle Inhalt der QuelleKudchadker, Rajat. „Optimized accelerator based epithermal neutron beams for boron neutron capture therapy /“. free to MU campus, to others for purchase, 1996. http://wwwlib.umi.com/cr/mo/fullcit?p9821332.
Der volle Inhalt der QuelleChung, Yoonsun. „Radiobiological evaluation of new boron delivery agents for boron neutron capture therapy“. Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/44784.
Der volle Inhalt der QuelleIncludes bibliographical references (p. 123-132).
This thesis evaluates the radiobiological effectiveness of three new boron compounds namely a boronated porphyrin (BOPP) and two liposome formulations for neutron capture therapy (BNCT). The methodology utilizes in vitro and in vivo comparisons that characterize compounds relative to boric acid and boronophenylalanine (BPA). In vitro evaluations utilized a colorimetric assay and 96-well plates to minimize the quantities of compound required for testing. The assay was optimized for the murine SCCVII, squamous cell carcinoma to determine the chemical toxicity and relative cellular uptake of a compound. BOPP was toxic at low concentrations and comparisons between the different compounds for thermal neutron irradiations were performed with approximately 5 [mu]g 10B/ml in the culture medium to allow radiation induced effects to govern the observed response. Using less than 300 [mu]g of compound and 250 kVp X-rays as control irradiations, a compound biological effectiveness (CBE) of 3.3 ± 0.7 was determined for BOPP that is comparable to the result for boric acid (3.5 ± 0.5) indicating a non-selective intracellular accumulation of 10B. BPA has a significantly higher CBE of 6.1 + 0.7. Boronated liposomes (MAC-16 and MAC+TAC) were evaluated with the EMT-6 murine mammary carcinoma. Biodistribution studies showed high 10B uptake in tumor (20-40 [mu]g 10B/g) 30 hours after a single i.v. injection (dose 6-20 [mu]g 10B per gram of body weight). Tumor control experiments were performed using thermal neutrons to study the efficacy of the boron delivered by liposomes and BPA. The MAC-16 produced a 16 % tumor control and BPA (dose 43 [mu]g 10B/gbw) 63 % for tumor boron concentrations of approximately 20 [mu]g 10B/g and the same neutron fluence.
(cont.) Liposome doses were limited by injection volume and so two injections were tried 2-hours apart that doubled the boron concentration in tumor compared to a single administration. This improved the therapeutic response to 67 % with less apparent skin damage than with BPA. Microscopic studies using fluorescent labeled liposomes revealed 10B was nonuniformly distributed and concentrated at the edge of the tumor. Based on these studies in the tumor cell lines chosen neither of the compounds appear superior to BPA.
by Yoonsun Chung.
Ph.D.
Bücher zum Thema "Boron-neutron capture therapy"
Gabel, Detlef, und Ray Moss, Hrsg. Boron Neutron Capture Therapy. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2.
Der volle Inhalt der Quelle1932-, Hatanaka Hiroshi, Hrsg. Boron-neutron capture therapy for tumors. Niigata, Japan: Nishimura, 1986.
Den vollen Inhalt der Quelle finden1929-, Mishima Yutaka, und International Symposium on Neutron Capture Therapy (6th : 1994 : Kōbe-shi, Japan), Hrsg. Cancer neutron capture therapy. New York: Plenum Press, 1996.
Den vollen Inhalt der Quelle findenNievaart, Victor Alexander. Spectral tailoring for boron neutron capture therapy. Amsterdam: IOS Press, 2007.
Den vollen Inhalt der Quelle findenH, Soloway Albert, Barth Rolf F, Carpenter David E. 1943-, International Society for Neutron Capture Therapy., International Union against Cancer, Arthur G. James Cancer Hospital and Research Institute. und International Symposium on Neutron Capture Therapy (5th : 1992 : Columbus, Ohio), Hrsg. Advances in neutron capture therapy. New York: Plenum Press, 1993.
Den vollen Inhalt der Quelle findenRoss, David Ian. Various studies relating to boron neutron capture therapy. Birmingham: University of Birmingham, 1992.
Den vollen Inhalt der Quelle findenBörje, Larsson, Crawford John und Weinreich Regin, Hrsg. Advances in neutron capture therapy: Proceedings of the Seventh International Symposium on Neutron Capture Therapy for Cancer, Zürich, Switzerland, 4-7 September 1996. Amsterdam: Elsevier, 1997.
Den vollen Inhalt der Quelle findenHosmane, Narayan S. Boron and gadolinium neutron capture therapy for cancer treatment. Singapore: World Scientific, 2012.
Den vollen Inhalt der Quelle findenG, Fairchild Ralph, Bond Victor P und Woodhead Avril D, Hrsg. Clinical aspects of neutron capture therapy. New York: Plenum Press, 1989.
Den vollen Inhalt der Quelle findenNational Cancer Institute (U.S.). Division of Cancer Treatment. Radiation Research Program und Boron Workshop (1988 : Annapolis, Md.), Hrsg. Boron compounds suitable for neutron capture therapy for the treatment of cancer. [Bethesda, MD: The Program, 1988.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Boron-neutron capture therapy"
Yanch, Jacquelyn C. „Boron Neutron Capture Synovectomy“. In Neutron Capture Therapy, 521–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-31334-9_31.
Der volle Inhalt der QuelleNakagawa, Yoshinobu. „Boron Neutron Capture Therapy“. In Frontiers in Neutron Capture Therapy, 73–79. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1285-1_6.
Der volle Inhalt der QuellePerks, Christopher A., und Howard J. Delafield. „Neutron Spectrometry Measurements of the Petten HFR, HB11 Neutron Beam“. In Boron Neutron Capture Therapy, 79–91. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_10.
Der volle Inhalt der QuelleMauri, Pier Luigi, und Fabrizio Basilico. „Proteomic Investigations for Boron Neutron Capture Therapy“. In Neutron Capture Therapy, 189–200. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-31334-9_10.
Der volle Inhalt der QuelleKawabata, Shinji, und Shin-Ichi Miyatake. „Boron Neutron Capture Therapy for Malignant Meningiomas“. In Neutron Capture Therapy, 399–406. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-31334-9_22.
Der volle Inhalt der QuelleHondros, E. D. „Opening Speech“. In Boron Neutron Capture Therapy, 1–3. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_1.
Der volle Inhalt der QuelleRaaijmakers, Cornelis P. J., Luc Dewit, Mark W. Konijnenberg, Ben J. Mijnheer, Raymond L. Moss und Finn Stecher-Rasmussen. „A Semi-Empirical Method of Treatment Planning for Boron Neutron Capture Therapy“. In Boron Neutron Capture Therapy, 93–100. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_11.
Der volle Inhalt der QuelleWatkins, Peter. „Present Status of the Three-Dimensional Treatment Planning Methodologies for the Petten BNCT Facility“. In Boron Neutron Capture Therapy, 101–9. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_12.
Der volle Inhalt der QuelleCoderre, Jeffrey A. „A Phase 1 Biodistribution Study of p-Boronophenylalanine“. In Boron Neutron Capture Therapy, 111–21. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_13.
Der volle Inhalt der QuelleGahbauer, Reinhard A., Ralph G. Fairchild, Joseph H. Goodman und Thomas E. Blue. „RBE in Normal Tissue Studies“. In Boron Neutron Capture Therapy, 123–28. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_14.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Boron-neutron capture therapy"
Stecher‐Rasmussen, F., R. L. Moss und M. W. Konijnenberg. „Boron Neutron Capture Therapy“. In Capture gamma‐ray spectroscopy. American Institute of Physics, 1991. http://dx.doi.org/10.1063/1.41154.
Der volle Inhalt der QuelleHaque, A. M., G. Moschini, Vlado Valkovic und D. Zafiropoulos. „Boron-neutron capture therapy“. In 4th International Conference on Applications of Nuclear Techniques: Neutrons and their Applications, herausgegeben von George Vourvopoulos und Themis Paradellis. SPIE, 1995. http://dx.doi.org/10.1117/12.204194.
Der volle Inhalt der QuelleGabel, Detlef. „Boron neutron capture therapy: from physics to treatment“. In Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, herausgegeben von George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267842.
Der volle Inhalt der QuelleKanda, Keiji. „Experience of boron neutron capture therapy in Japan“. In Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, herausgegeben von George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267900.
Der volle Inhalt der QuelleTaskaev, Sergey. „Neutron source VITA for Boron Neutron Capture Therapy and other applications“. In RAD Conference. RAD Centre, 2021. http://dx.doi.org/10.21175/rad.abstr.book.2021.16.2.
Der volle Inhalt der QuelleHerrera, María S., Sara J. González, Daniel M. Minsky, Andrés J. Kreiner, Ricardo Alarcon, Phil Cole, Andres J. Kreiner und Hugo F. Arellano. „Treatment Planning for Accelerator-Based Boron Neutron Capture Therapy“. In VIII LATIN AMERICAN SYMPOSIUM ON NUCLEAR PHYSICS AND APPLICATIONS. AIP, 2010. http://dx.doi.org/10.1063/1.3480233.
Der volle Inhalt der QuelleShefer, Ruth E., Robert E. Klinkowstein und Jacquelyn C. Yanch. „High-current electrostatic accelerator for boron neutron capture therapy“. In Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, herausgegeben von George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267922.
Der volle Inhalt der QuelleYanch, J. C., R. E. Shefer, R. E. Klinkowstein, W. B. Howard, H. Song, B. Blackburn und E. Binello. „Research in Boron Neutron Capture Therapy at MIT LABA“. In The fourteenth international conference on the application of accelerators in research and industry. AIP, 1997. http://dx.doi.org/10.1063/1.52637.
Der volle Inhalt der QuelleSingh, Bikramjeet, Paviter Singh, Manjeet Kumar, Anup Thakur und Akshay Kumar. „Single step synthesis of nanostructured boron nitride for boron neutron capture therapy“. In PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON CONDENSED MATTER PHYSICS 2014 (ICCMP 2014). AIP Publishing LLC, 2015. http://dx.doi.org/10.1063/1.4915415.
Der volle Inhalt der QuelleKanygin, V. V., A. I. Kichigin, A. L. Krivoshapkin und S. Yu Taskaev. „Perspectives of boron-neutron capture therapy of malignant brain tumors“. In PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS: Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications (PC IPCA’17). Author(s), 2017. http://dx.doi.org/10.1063/1.5001609.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Boron-neutron capture therapy"
Maughan, R. L., und C. Kota. Microdosimetry for Boron Neutron Capture Therapy. Office of Scientific and Technical Information (OSTI), September 2000. http://dx.doi.org/10.2172/770637.
Der volle Inhalt der QuelleN. Commercial Clinical Application of Boron Neutron Capture Therapy. Office of Scientific and Technical Information (OSTI), September 1999. http://dx.doi.org/10.2172/942161.
Der volle Inhalt der QuelleDolan, T., E. Ottewitte, E. Wills, W. Neuman und D. Woodall. Non-reactor neutron sources for BNCT (Boron Neutron Capture Therapy). Office of Scientific and Technical Information (OSTI), Mai 1989. http://dx.doi.org/10.2172/5876401.
Der volle Inhalt der QuelleWang, Zhonglu. Design of a boron neutron capture enhanced fast neutron therapy assembly. Office of Scientific and Technical Information (OSTI), Dezember 2006. http://dx.doi.org/10.2172/892403.
Der volle Inhalt der QuelleSweezy, Jeremy Ed. Development of a Boron Neutron Capture Enhanced Fast Neutron Therapy Beam. Office of Scientific and Technical Information (OSTI), Januar 2002. http://dx.doi.org/10.2172/1420958.
Der volle Inhalt der QuelleJ. Vujic, E. Greenspan, W.E. Kastenber, Y. Karni, D. Regev, K. N. Leung J.M. Verbeke, D. Chivers et al. Optimal Neutron Source & Beam Shaping Assembly for Boron Neutron Capture Therapy. Office of Scientific and Technical Information (OSTI), April 2003. http://dx.doi.org/10.2172/810841.
Der volle Inhalt der QuelleBarnum, Beverly A., Yan Hao, Roger Moore, M. Frederick Hawthorne und Kurt Baum. Carborane derivative development for boron neutron capture therapy. Final report. Office of Scientific and Technical Information (OSTI), April 1999. http://dx.doi.org/10.2172/762720.
Der volle Inhalt der QuelleDorn, R. V. III. Power Burst Facility/Boron Neutron Capture Therapy Program for cancer treatment. Herausgegeben von A. L. Ackermann. Office of Scientific and Technical Information (OSTI), August 1990. http://dx.doi.org/10.2172/6321857.
Der volle Inhalt der QuelleAckermann, A. L., Hrsg. Power Burst Facility/Boron Neutron Capture Therapy Program for cancer treatment. Office of Scientific and Technical Information (OSTI), Oktober 1990. http://dx.doi.org/10.2172/6141929.
Der volle Inhalt der QuelleDorn, R. V. III. Power Burst Facility/Boron Neutron Capture Therapy Program for cancer treatment. Herausgegeben von A. L. Ackermann. Office of Scientific and Technical Information (OSTI), September 1990. http://dx.doi.org/10.2172/6168994.
Der volle Inhalt der Quelle